New Black Book Research report, based on approximately 1,280 qualified U.S. oncology stakeholders, identifies the top-rated ...
Morning Overview on MSN
Experimental pancreatic cancer treatments spark new optimism in trials
For decades, a diagnosis of metastatic pancreatic cancer has carried one of the shortest survival timelines in oncology.
With more accessible AI models shifting the landscape of cancer research and treatments, scientists weigh in on whether AI ...
At AACR 2026, researchers discussed the promise and challenges of bringing AI-powered tools into cancer research and clinical ...
A recently published study from Fred Hutch Cancer Center dramatically expands the number of FDA-approved cancer drugs ...
Updated cervical cancer screening guidance from the American College of Obstetricians and Gynecologists endorsed at-home ...
Ferris State University received a $1.92 million grant from the U.S. Department of Commerce's National Institute of Standards ...
A new report from Cancer Research UK has suggested that young adults are frequently being diagnosed with bowel cancer, with ...
The field of cancer immunotherapy and immunology is rapidly reshaping modern oncology, yet the translational gap between mechanistic discoveries and durable ...
Surprising new research has found that eating a healthy diet packed with fruits, vegetables, and whole grains may lead to a ...
A new study from Karolinska Institutet shows that gene analysis of breast cancer tumors can identify patients who do not ...
SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results